805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours

by Mark Lythgoe, Jonathan Krell, Axel Glasmacher, Justin Stebbing, Emily Pickford, Marsilio Adriani, Gayle Fyvie, Adam Frampton, Alex Stevenson
Published 2020-11-01

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ

by Kirsty E. Waddington, Kirsty E. Waddington, Artemis Papadaki, Leda Coelewij, Leda Coelewij, Marsilio Adriani, Petra Nytrova, Eva Kubala Havrdova, Anna Fogdell-Hahn, Rachel Farrell, Pierre Dönnes, Pierre Dönnes, Inés Pineda-Torra, Elizabeth C. Jury
Published 2020-07-01

Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients

by Laura Magill, Marsilio Adriani, Véronique Berthou, Keguan Chen, Aude Gleizes, Aude Gleizes, Salima Hacein-Bey-Abina, Salima Hacein-Bey-Abina, Agnes Hincelin-Mery, Xavier Mariette, Marc Pallardy, Sebastian Spindeldreher, Natacha Szely, David A. Isenberg, Jessica J. Manson, Elizabeth C. Jury, Claudia Mauri
Published 2018-12-01